High-dose fibrinogen concentrate for haemostatic therapy of a major trauma patient with recent clopidogrel and aspirin intake

Scand J Clin Lab Invest. 2010 Oct;70(6):453-7. doi: 10.3109/00365513.2010.500396.

Abstract

Introduction: We report on a severely injured trauma patient who suffered a high velocity motorcycle accident. The patient was receiving dual antiplatelet therapy with aspirin and clopidogrel.

Methods and results: Thromboelastometry (ROTEM(®)) on admission revealed low maximum clot firmness (MCF) in the FIBTEM assay, strongly indicating impaired fibrin polymerization. Inhibition of platelet activity also was confirmed. Massive intra-abdominal bleeding caused by a liver rupture required immediate laparotomy. Haemostasis during emergency surgery was achieved through topical surgical measures and intravenous fibrinogen concentrate administration (three doses of 4 g), guided by ROTEM test results only. As platelet count decreased to 28 × 10(9) L(-1), 6 h after admission to the intensive care unit, the patient received two units of platelet concentrate. No further haemostatic therapy was necessary during the next 48 h.

Conclusion: This case shows the potential effectiveness of fibrinogen concentrate in improving haemostasis in trauma patients receiving antiplatelet therapy.

Trial registration: ClinicalTrials.gov NCT00701142.

Publication types

  • Case Reports

MeSH terms

  • Aspirin / therapeutic use*
  • Clopidogrel
  • Drug Interactions
  • Fibrinogen / administration & dosage
  • Fibrinogen / therapeutic use*
  • Glasgow Coma Scale
  • Hemorrhage / drug therapy
  • Hemorrhage / physiopathology
  • Hemostatics / administration & dosage
  • Hemostatics / therapeutic use*
  • Humans
  • Injections, Intravenous
  • Male
  • Middle Aged
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Thrombelastography / methods
  • Ticlopidine / analogs & derivatives*
  • Ticlopidine / therapeutic use
  • Treatment Outcome
  • Wounds and Injuries / physiopathology
  • Wounds and Injuries / therapy*

Substances

  • Hemostatics
  • Platelet Aggregation Inhibitors
  • Fibrinogen
  • Clopidogrel
  • Ticlopidine
  • Aspirin

Associated data

  • ClinicalTrials.gov/NCT00701142